News & Updates

Air pollution in pregnancy perturbs development of offspring’s immune system

21 Sep 2022

Prenatal exposure to air pollution appears to disrupt immune development in the offspring’s early life, in turn increasing the risk of allergic rhinitis and asthma, a recent study has found.

Air pollution in pregnancy perturbs development of offspring’s immune system

21 Sep 2022

Aspirin prophylaxis beneficial in recurrent preterm birth

21 Sep 2022 by

The use of low-dose aspirin among women who have had a preterm birth appears to lower the risk of recurrence, as shown in a study.

Aspirin prophylaxis beneficial in recurrent preterm birth

21 Sep 2022

Levonorgestrel-releasing intrauterine system delivers prolonged effects

18 Sep 2022

The long-acting contraceptive option, 52-mg levonorgestrel-releasing intrauterine system (52-mg LNG-IUS), appears to be highly effective, with high user satisfaction and a favourable safety profile, through 8 years of use, according to data from the Mirena Extension Trial.

Levonorgestrel-releasing intrauterine system delivers prolonged effects

18 Sep 2022

Second-hand smoke during first trimester ups CHD risk in infants

18 Sep 2022

Mothers exposed to environmental tobacco smoke (ETS) during the first trimester of pregnancy are more likely to give birth to infants with congenital heart defects (CHD), a recent study has found.

Second-hand smoke during first trimester ups CHD risk in infants

18 Sep 2022

Dinoprostone outperforms misoprostol at inducing labour

17 Sep 2022

Vaginal dinoprostone appears to be a better labour-inducing agent than vaginal misoprostol, leading to lower rates of foetal complications, a recent study has found.

Dinoprostone outperforms misoprostol at inducing labour

17 Sep 2022

Probiotics help reduce mastitis during lactation

17 Sep 2022

For breastfeeding mothers, taking probiotics may help decrease the likelihood of developing mastitis and related symptoms during lactation, reports a recent meta-analysis.

Probiotics help reduce mastitis during lactation

17 Sep 2022

First-line rucaparib boosts PFS in ovarian cancer regardless of HRD status

15 Sep 2022 by

First-line rucaparib maintenance therapy extends progression-free survival (PFS) in patients with ovarian, fallopian tube, or primary peritoneal cancer, according to results of the phase III ATHENA-MONO trial presented at the ESMO Gynaecological Cancers Conference 2022.

First-line rucaparib boosts PFS in ovarian cancer regardless of HRD status

15 Sep 2022

Higher periconception RBC folate tied to lower offspring CHD risk

15 Sep 2022

Greater maternal red blood cell (RBC) folate, the gold-standard biomarker of folate exposure, appears to lower the risk of offspring congenital heart disease (CHD), reveals a study.